LEUKOGENE THERAPEUTICS INC
Homepage - Leukogene
Mount Pleasant, United States · Founded 2016
- Headquarters
- Mount Pleasant, South Carolina
- Employees
- 1–10
- Founded
- 2016
- Business Model
- B2G
- Website
- leukogene.com
About
Leukogene Therapeutics is a preclinical-stage biopharmaceutical company developing next-generation immunotherapies for hard-to-treat cancers, with an emphasis on immunologically cold tumors. Its lead asset M2T-CD33 (LTI-214) received FDA Orphan Drug Designation in November 2025 for acute myeloid leukemia treatment. The company is backed by SCRA, MUSC's 1824 Health Ventures fund, and NIH SBIR grants.
Summary
LEUKOGENE THERAPEUTICS INC is a Biotech company based in Mount Pleasant, United States, founded in 2016.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/leukogene-therapeutics-inc"><img src="https://indexed.vc/api/badge/company/leukogene-therapeutics-inc" alt="LEUKOGENE THERAPEUTICS INC on Indexed.vc" width="260" height="76" /></a>